Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome

Clinical Pharmacology and Therapeutics

Volumn 68, Issue 5, 2000, Pages 532-540

  Hirano, Toshihiko ^a   Akashi, Takao ^b   Keira, Takayuki ^a   Oka, Kitaro ^a   Ihoya, Noriko ^b   Yoshida, Masaharu ^b  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CYCLOSPORIN; INTERLEUKIN 2; PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE TRANSFORMATION; MALE; MITOSIS INHIBITION; MONONUCLEAR CELL; NEPHROTIC SYNDROME; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REMISSION;

ADULT; CELLS, CULTURED; CYCLOSPORINE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOSIS; NEPHROSIS, LIPOID;

EID: 0033679907     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.110773     Document Type: Article

References (22)

1. Cyclosporine in ulcerative colitis
2. Treatment of psoriasis
3. A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation
4. A randomized trial of cyclosporine in steroid-resistant idiopathic nephritic syndrome
5. Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome
6. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy
7. The glomerular polyanion (GPA) of the rat kidney. I. Concanavalin-A-activated cells affect the glomerular polyanion in vitro
8. A glomerular permeability factor produced by human T cell hybridomas
9. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis and psoriasis: Possible implications for individual therapeutic efficacy
10. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis
11. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation: Marked difference between prednisolone and methylprednisolone
12. The mechanism of action of cyclosporin A and FK506
13. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
14. Suppression of dialysis patient's lymphocyte IL-2R expression by glucocorticoids and cyclosporine
15. A mutation of the glucocorticoid receptor in primary cortisol resistance
16. Gramicidin as a potential immunosuppressant for organ transplantation
17. Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes
18. Lymphocyte-sensitivities to cyclosporine and tacrolimus in chronic renal failure patients and their significance on renal transplantation
19. Lymphocyte responsiveness to glucocorticoids, cyclosporine, or both
20. Inhibition of stimulated interleukin-2 production in whole blood: A practical measure of cyclosporine effect
21. Calcineurin mutants render T lymphocytes resistant to cyclosporine A